Published in
Elsevier, Cancer Treatment Reviews, (44), p. 26-41, 2016
DOI: 10.1016/j.ctrv.2016.01.005
Links
Tools
Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?
Journal article published in 2016 by
Angela Lamarca 
,
Emma Elliott,
Jorge Barriuso,
Alison C. Backen,
Mairéad G. McNamara,
Richard A. Hubner,
Juan W. Valle
,
Emma Elliott,
Jorge Barriuso,
Alison C. Backen,
Mairéad G. McNamara,
Richard A. Hubner,
Juan W. Valle
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Chemotherapy is well-established in the treatment of patients with well-differentiated neuroendocrine tumours (NETs) arising from the pancreas (pNETs); however, its role in patients with gastrointestinal non-pancreatic NETs (non-pNETs) is uncertain. This systematic review assesses the evidence for the role of chemotherapy in well-differentiated non-pNET patients.